Cervical Cancer Screening—Moving From the Value of Evidence to the Evidence of Value-Reference-Cited by-同舟云学术

Cervical Cancer Screening—Moving From the Value of Evidence to the Evidence of Value

Published:2018-10-01 Issue:10 Volume:178 Page:1293
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Sawaya George F.¹²³

Affiliation:

1. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco

2. Department of Epidemiology & Biostatistics, University of California, San Francisco

3. Center for Healthcare Value, University of California, San Francisco

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Reference18 articles.

1. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.;Leyden;J Natl Cancer Inst,2005

2. Screening for cervical cancer: US Preventive Services Task Force recommendation statement;US Preventive Services Task Force;JAMA

3. Screening for cervical cancer in primary care: a decision analysis for the US Preventive Services Task Force;Kim;JAMA

4. Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force;Melnikow;JAMA

5. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.;Huh;Gynecol Oncol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cervical cancer screening in Jordan; a review of the past and an outlook to the future – facts and figures;Menopausal Review;2023

2. When and How Would You Screen This Patient for Cervical Cancer?;Annals of Internal Medicine;2022-02

3. HPV Tip 66’yi Olasi Yuksek Riskli Grupta Degerlendirmeli miyiz? Ankara Gazi Universitesi’ndeki HPV Tip 66’nin Prevalansi, Klinik ve Histopatolojik Degerlendirmesi;Gazi Medical Journal;2021-01-01

4. Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells;Cancer Cell International;2019-05-14

5. An advocacy victory: final USPSTF cervical cancer screening recommendations revised to include cotesting option;Journal of the American Society of Cytopathology;2018-11